Machine Learning

The 2026 International Quant Championship kicks off with record growth, leveraging AI and a global platform to turn aspiring data scientists into finance pros.

Exiting stealth, PerturbAI releases an 8-million-cell map of gene function in a living brain, aiming to slash the cost and time of creating new drugs.

As AI coding tools create a 'visibility crisis,' a new platform aims to restore order by giving teams a real-time map of their evolving software.

As HireQuest preps its 2025 results, investors watch if its franchise model can navigate a cooling, tech-driven labor market and offer clues for 2026.

In a strategic move to capture more market share, Knowtion Health's buyout of revly adds powerful, EHR-agnostic billing tech to its growing platform.

Facing a storm of IT complexity? DH2i's new DxEnterprise and DxOperator releases promise to simplify SQL Server resilience across hybrid and cloud-native worlds.

Backed by dialysis giants DaVita and U.S. Renal Care, a new startup licenses a first-in-class therapy to transform treatment for kidney patients.

BioCardia's FDA milestone for its Helix catheter could unlock a new era of targeted heart therapies, but financial hurdles and clinical questions remain.

The world's largest agrochemical expo opens, showcasing a major shift to sustainable solutions and cementing China's central role in global food security.

UK biotech Alchemab hires Sanofi's Ulrich Wendt as CBO to forge major pharma deals for its novel AI platform that mines the secrets of human resilience.

A new biotech firm unveils a first-in-class cancer drug targeting E6AP, aiming to restore the body's natural defenses against HPV-positive head and neck cancer.

Vaisala revamps its financial reporting to showcase its fast-growing Xweather data service, signaling a strategic shift into the booming climate tech market.

The global consulting firm launches a tech-driven Valuations practice, aiming to deliver faster, AI-powered insights in a volatile economic landscape.

Pharma giant AbbVie taps biotech innovator Alloy Therapeutics to build a novel antibody platform, aiming to unlock a new generation of medicines.

Showcasing its Cogynt.ai platform, Cogility plans to shift security from reactive detection to proactive, behavior-based prevention of insider risks.

Princess Padmaja Kumari Parmar receives the Mary Tyler Moore Award for her advocacy, bridging a legacy of hope with a modern fight for global T1D equity.

Ethernovia launches a new networking platform for NVIDIA Holoscan, unifying high-speed sensor data with Omniverse digital twin simulations at the edge.

OTI Lumionics' new method on a single GPU simulates complex molecules in one hour, a task that could take a future quantum computer up to 200 hours.

Hyundai Motor Group and NVIDIA are expanding their partnership, aiming to dominate the future of autonomous vehicles with a data-driven, two-pronged strategy.

Aerospace tech firm Merlin lands on NASDAQ, securing capital to scale its AI-powered autonomous flight system for military and future civilian aircraft.